Clinical trial

A Study Providing Treatment Access in Participants With Pulmonary Hypertension Completing a Parent Study and Having no Other Option

NCT05179876

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2022-05-04

PhasePHASE3

Study timeline

Study start (actual)2022-05-04Date precision: day

Registry last updated2026-09-25

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Hypertension, Pulmonaryunresolved

Interventions

MacitentanDRUG · verified · RxNorm: macitentan

SelexipagDRUG · verified · RxNorm: selexipag

Macitentan/Tadalafil FDCDRUG

Sponsors & collaborators

Actelionlead sponsor

Mapped research locations

SeoulSouth Korea5 TaipeiTaiwan2 BeijingChina2 WroclawPoland2 BudapestHungary1 Saint PetersburgRussia1 ShanghaiChina1 LeuvenBelgium1 SofiaBulgaria1 LodzPoland1 BialystokPoland1 LublinPoland1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05179876 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.